Aptagen, LLC
            
                
                    
                                                     
                                            
                                    
                
                                            
            
            
            
            
        
    1G8-14 (ID# 7934)
 
                                            
                            
                            RNA
                        
                    
                                            
                            
                            Ebola virus inhibitory domain (eVP35 IID) (EBOV) (eVP35)
                        
                    
                                            
                            
                            Protein
                        
                    
                                            
                            
                            3.7 nM (reported value)
                        
                    
                                            
                            
                            10mM HEPES (pH 7.0), 150mM NaCl, 2mM TCEP (tris(2-carboxyethyl)phosphine), 1mM MgCl2
                        
                    
                                            
                            
                            37°C
                        
                    
                    
                        
                        
                                                            NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.                         
                    
                    
                                    
                
                
                    rGprGprGprAprGprAprCprAprAprGprAprApUrAprAprAprCprGprCpUrCprAprAprGprGprCprApUUUrCpUrGprCpUrAprGpUrCpUrGprGpUUrGpUrAprAprGprApUrApUUrCprAprAprCprAprCprGpUrGprAprGpUUUrCprGprAprCprAprGprGprAprGprGprCpUrCprAprCprAprAprCprAprGprGprCp
                
                
                     
                
                                    
                        
                        
                            
                    
                
                
                
            
            
         
                
                        
                        70
                    
                
                                    
                        
                        22934.2
                    
                            
                                    
                        
                        715100
                    
                            
                
                
                Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Jennifer M. Binning, Tianjiao Wang, Priya Luthra, Reed S. Shabman, Dominika M. Borek, Gai Liu, Wei Xu, Daisy W. Leung, Christopher F. Basler, and Gaya K. Amarasinghe, ƒ??Development of RNA aptamers targeting ebolavirus VP35ƒ? Biochemistry 2013, 52, 8406-8419.
Have your aptamer oligo synthesized ORDER



We are always looking for ways to improve. Please tell us what you think.